15 October 2019

T3 Pharmaceuticals AG, a Basel-based company focusing on immuno-oncology, closes its second financing round of over 12M CHF with existing investors joined by Boehringer Ingelheim Venture Fund (BIVF) and Reference Capital SA.

VISCHER acts as legal advisor to T3 Pharmaceuticals AG in the financing round. The team includes Christian Wyss (Partner, Corporate / M&A), Moritz Jäggy (Associate, Corporate / M&A), Francesca Pesenti (Associate, Corporate / M&A), and Pauline Pfirter (Associate, Corporate / M&A).

Categories: Life Sciences, Pharma, Biotech, Mergers & Acquisitions, Private Equity & Venture Capital

You are currently offline. Some pages or content may fail to load.